Synopses & Reviews
The second edition of this book was necessary in order to accommodate the rapid rise of interest in this subject. It provides a concise summary of these developments from the bench to the bedside. At stake is the enormous importance of the issue at hand: how to select the patient with severe left ventricular dysfunction who may benefit from coronary revascularization. This is the crux of the matter, knowing that medical therapy in these patients carries a poor outcome even with the newer drugs and that cardiac transplantation is possible in only a few. This book should prove to be a valuable aid to those providing the technical aspects of procedure as well as those who manage such patients, physicians and surgeons alike. It should be in every medical library and on the desk of every medical student, internist, cardiologist, cardiac surgeon, anesthesiologist, nuclear medicine specialist and radiologist.
Review
`...the coverage of the various modalities is quite comprehensive. The book is very well referenced and contains plenty of figures and tables... This volume will appeal to cardiologists, echocardiographers, nuclear physicians, surgeons and others and would make a useful acquisition to an institutional library.' ANZ Nuclear Medicine, 32:1 (2001)
Review
`...the coverage of the various modalities is quite comprehensive. The book is very well referenced and contains plenty of figures and tables... This volume will appeal to cardiologists, echocardiographers, nuclear physicians, surgeons and others and would make a useful acquisition to an institutional library.'
ANZ Nuclear Medicine, 32:1 (2001)
Table of Contents
Contributors list. Introduction by the editors. 1. Hibernating and stunned myocardium: pathophysiological considerations; M. Schwaiger, U. Schricke 2. Role of apoptosis in myocardial hibernation and myocardial stunning; R. Baliga, et al. 3. Assessment of myocardial viability with positron emission tomography; H.R. Schelbert. 4. Assessment of myocardial viability by thallium-201; J.J. Bax, et al. 5. Technetium-99m-labeled perfusion tracers for the detection of myocardial viability; R. Sciagr